Future prostate cancer treatment could be targeted at a newly discovered protein which is specific to the
tumours found in the gland.
Scientists believe that effective drugs can be developed to target the PKCZ
protein and subsequently reduce the amount of deaths that are attributed to
prostate cancer - a figure which currently stands at 10,700 every year in the
UK.
Dr Julie Sharp, senior science information manager at Cancer Research UK,
said: "With more than 40,000 men now diagnosed each year with the disease
there's an urgent need to develop tests that tell us how the disease is
behaving."
She explained that this research highlights how complicated cancer genetics can
be, but stressed that any knowledge garnered could help to save lives.
© Adfero Ltd
Prostate cancer treatment news : 1 June 2012
